Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

3.460

+0.160 (4.85%)

At close: Apr 30, 2026, 4:00 PM EDT

3.469

+0.009 (0.25%)

After-hours: Apr 30, 2026, 7:59 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	74.68M	58.84M	44.58M	39.84M	10.18M
Pharmaceuticals Growth	26.92%	32.00%	11.88%	291.46%	156.89%
Total	74.68M	58.84M	44.58M	39.84M	10.18M
Total Growth	26.92%	32.00%	11.88%	291.46%	156.89%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	39.34M	57.38M	43.81M	39.84M	10.18M
United States Growth	-31.43%	30.98%	9.95%	291.46%	156.89%
United Kingdom	35.34M	1.14M	-	-	-
United Kingdom Growth	3013.39%	-	-	-	-
Other	-	327.00K	769.00K	-	-
Other Growth	-	-57.48%	-	-	-
Total	74.68M	58.84M	44.58M	39.84M	10.18M
Total Growth	26.92%	32.00%	11.88%	291.46%	156.89%

Source: S&P Global Market Intelligence.